The Research and Development team at Wugen focuses on advancing innovative immuno-oncology therapies, specifically off-the-shelf NK and CAR-T cell treatments. This team, comprising experts in cell biology and oncology, conducts preclinical research to optimize therapeutic efficacy, investigates novel applications for their therapies, and collaborates on clinical trial designs to bring breakthrough cancer treatments to patients.